Ineos to Acquire Spain’s Befesa

Ineos Enterprises has announced its intention to buy 100% of the shares of Spain’s leading sulfuric acid and oleum producer, Befesa Valorizacion de Azufre (BVA).

Located in Bilbao, northern Spain, BVA’s plant has the capacity to produce 340,000 t/y sulfuric acid and related products. Ineos said the facility, which was commissioned in October 2011, is one of the most modern in Europe.

The acquisition will complement Ineos’s existing sulfur chemicals business in the UK, effectively doubling its production capacity. “The asset is ideally situated to competitively source raw materials and to serve the domestic market, with excellent access to export markets,” said Ashley Reed, CEO of Ineos Enterprises.

The transaction is expected to complete at the end of December. The purchase price was not disclosed.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
27.03.2025 • News

Moeve Joins Global Impact Coalition

The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.